Home / Import refusals / BPQ-7014562-3/1/1

FDA Import Refusal BPQ-7014562-3/1/1 — Mayne Pharma International PTY LTD

Mayne Pharma International PTY LTD — FEI 3004090027

The FDA refused shipment BPQ-7014562-3/1/1 from Mayne Pharma International PTY LTD (Australia) on March 2, 2017. The refused product falls under Drugs and Biologics — ERYTHROMYCIN ETHYLSUCCINATE (MACROLIDES). Cited charge: 118 This firm has 2 other import refusals on record.

Refusal Details

Date
March 2, 2017
Country
Australia
Product Category
Drugs and Biologics
Product Code
56IIS25 ERYTHROMYCIN ETHYLSUCCINATE (MACROLIDES)
Charges
118

Recent inspections

  • 1257835 (VAI Fri Mar 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110711 (VAI Fri Oct 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035729 (NAI Fri Sep 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945811 (VAI Fri Sep 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 846520 (VAI Fri Aug 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-0689980-3/11/1 (Mon Jul 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-3328257-6/31/1 (Thu Mar 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources